Dr. Reddy's Launches Generic Version Of Xeloda Tablets : vim

Dr. Reddy's Launches Generic Version Of Xeloda Tablets
NEW DELHI (dpa-AFX) - Dr. Reddy's Laboratories Ltd. (RDY), an integrated pharmaceutical company, announced the launch of Capecitabine Tablets, USP a therapeutic equivalent generic version of Xeloda Tablets approved by the FDA. Dr. Reddy's Capecitabine Tablets, USP are available in 150 mg and 500 mg strengths in bottle count sizes of 60 and 120, respectively.
Dr. Reddy's Laboratories noted that the Xeloda brand and generic had U.S. sales of approximately $90 million MAT for the most recent twelve months ending in October 2020 according to IQVIA Health.
Copyright RTT News/dpa-AFX
© 2021 AFX News

Related Keywords

, Reddy Laboratories Ltd , Capecitabine Tablets , Xeloda Tablets , Freddy , Launches , Generic , Version , Xeloda , Tablets , சிவப்பு ஆய்வகங்கள் லிமிடெட் , சிவப்பு , ஜெநெரிக் , பதிப்பு , மாத்திரைகள் ,